Jean‐Jacques Grob

机构：Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, Institut de Neurosciences de la Timone, Hôpital de la Timone · ORCID：0000-0002-0667-153X

发表论文 1007 篇 · 总被引 82109 次 · h-index 107

代表论文

A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors (2025 · Clinical Cancer Research · 被引 10)
Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76 K trial (2025 · European Journal of Cancer · 被引 10)
Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301) (2025 · Journal of Clinical Oncology · 被引 9)
Erratum: First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data (2025 · Journal of Clinical Oncology · 被引 2)
Administration of nivolumab plus ipilimumab: Infusion of the fixed‐ratio combination versus sequential infusions in two randomized controlled trials of metastatic melanoma (CheckMate 742) and renal cell carcinoma (CheckMate 800) (2025 · Cancer · 被引 1)
Erratum: Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301) (2025 · Journal of Clinical Oncology · 被引 1)